Portfolio (Quarterly)
Guide ↗
Arrowpoint Investment Partners (Singapore) Pte. Ltd.
· CIK 0002032331| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | IGV CALL | ISHARES TR | — | 230,800.0 | $18.5M | 16.42% | NEW | — | $80.05 | +15.5% |
| 2 | KWEB CALL | KRANESHARES TRUST | — | 400,000.0 | $11.4M | 10.11% | NEW | — | $28.43 | -2.8% |
| 3 | GOOGL | ALPHABET INC | Communication Services | 31,127.0 | $9.0M | 7.96% | +30K | +2123.4% | $287.56 | +34.8% |
| 4 | SMH PUT | VANECK ETF TRUST | — | 22,000.0 | $8.4M | 7.49% | NEW | — | $383.27 | +48.1% |
| 5 | EWZ CALL | ISHARES INC | — | 120,000.0 | $4.6M | 4.09% | NEW | — | $38.39 | -3.6% |
| 6 | ASX | ASE TECHNOLOGY HLDG CO LTD | Technology | 179,512.0 | $3.9M | 3.46% | NEW | — | $21.68 | +50.6% |
| 7 | IONS | IONIS PHARMACEUTICALS INC | Healthcare | 38,988.0 | $2.9M | 2.60% | +14K | +55.9% | $75.09 | +0.9% |
| 8 | NBIX | NEUROCRINE BIOSCIENCES INC | Healthcare | 21,556.0 | $2.8M | 2.52% | +18K | +512.9% | $131.74 | +18.0% |
| 9 | AXSM | AXSOME THERAPEUTICS INC. | Healthcare | 16,401.0 | $2.8M | 2.46% | +14K | +677.3% | $169.02 | +38.2% |
| 10 | BMRN | BIOMARIN PHARMACEUTICAL INC | Healthcare | 48,719.0 | $2.8M | 2.45% | NEW | — | $56.49 | -4.2% |
| 11 | — | ASCENDIS PHARMA A/S | — | 11,828.0 | $2.7M | 2.40% | +9K | +294.7% | $228.73 | — |
| 12 | PTCT | PTC THERAPEUTICS INC | Healthcare | 39,701.0 | $2.7M | 2.40% | +30K | +329.8% | $68.13 | +4.2% |
| 13 | PFE | PFIZER INC | Healthcare | 71,313.0 | $2.0M | 1.78% | +28K | +64.5% | $28.08 | -7.6% |
| 14 | REGN | REGENERON PHARMACEUTICALS | Healthcare | 2,502.0 | $1.9M | 1.72% | +964.0 | +62.7% | $772.64 | -15.9% |
| 15 | JNJ | JOHNSON & JOHNSON | Healthcare | 7,902.0 | $1.9M | 1.72% | -306K | -97.5% | $244.44 | -5.2% |
| 16 | AMGN | AMGEN INC | Healthcare | 4,934.0 | $1.7M | 1.54% | -1K | -17.2% | $351.85 | -4.1% |
| 17 | GILD | GILEAD SCIENCES INC | Healthcare | 11,961.0 | $1.7M | 1.48% | -7K | -38.4% | $139.37 | -6.4% |
| 18 | VRTX | VERTEX PHARMACEUTICALS INC | Healthcare | 3,412.0 | $1.5M | 1.35% | +48.0 | +1.4% | $446.54 | -3.6% |
| 19 | — | MICROCHIP TECHNOLOGY INC. | — | 1,500,000.0 | $1.5M | 1.32% | NEW | — | $0.99 | — |
| 20 | UNH | UNITEDHEALTH GROUP INC | Healthcare | 5,216.0 | $1.4M | 1.25% | NEW | — | $270.59 | +41.7% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
74.4%
Communication Services
15.8%
Technology
7.5%
Financial Services
2.0%
Basic Materials
0.2%
Real Estate
0.1%
Industrials
0.0%